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ABSTRACT
Helicobacter hepaticus is well established as an unwanted variable in laboratory rodent
colonies. Historically, caesarean section and embryo transfer have been used to derive
Helicobacter-free mouse colonies. Neonatal transfer of newborn mice onto Helicobacter-free
foster dams was recently reported as an alternative method of deriving Helicobacter-free mice,
but until now, the age by which pups must be fostered to remain Helicobacter-free was
unknown. The purpose of this study was to determine the age by which mouse pups must be
fostered to remain H. hepaticus-free. Beginning on the day of birth, 20 C57BL/6 mice were
fostered from H. hepaticus-positive parents onto Helicobacter-free BALB/c dams each day for
14 days for a total of 280 pups. Fecal specimens collected at weaning, and fecal, liver, and cecal
specimens collected at euthanasia were analyzed by use of polymerase chain reaction (PCR)
analysis. No pup fostered within 24 hours of birth became infected with H. hepaticus; however,
many of those fostered after 24 hours became infected. These results were supported by those of
a large field trial, in which 201 litters representing 71 strains of mice were fostered within 24
hours of birth. Follow-up fecal PCR analysis was performed on 52 mice or their progeny, which
were randomly sampled from the 201 fostered litters. All mice tested remained free of H.
hepaticus approximately 100 days after fostering. The results indicate that mouse pups must be
fostered within 24 hours of birth in order to remain free of H. hepaticus. In addition, cecal and
fecal PCR analyses detected more infections, than did liver PCR analysis, thus indicating that
those specimens are preferred for detection of H. hepaticus infection. Lastly, adult C57BL/6
mice were found to shed H. hepaticus intermittently. The sires contributed most of the bacterial
load, and thus, exposure to the newborn pups.
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INTRODUCTION
Bacteria of the genus Helicobacter have been given much attention since Helicobacter
pylori was isolated and pronounced the causative agent of human patients suffering from chronic
gastritis and peptic ulcer disease (Marshall and Warren, 1984). To date, at least 34 species of
Helicobacter have been identified and the number of novel species described continues to
increase. Mice are susceptible to infection with H. bilis, H. ganmani, H. hepaticus, H. rodentium,
H. typhlonius, H. muricola, and H. muridarum. Helicobacter hepaticus is considered a primary
pathogen of mice and Koch’s postulates have been fulfilled confirming its association with
hepatitis (Fox et al., 1996b).
Helicobacter hepaticus is a gram negative, motile bacterium of variable morphology. It
has bipolar, single-sheathed flagella, unlike many other species which have multiple polar
flagella. It may appear as rods, cocci, or spirochetes, and varies in diameter and length (0.2 um
to 0.3 um by 1.5 um to 5.0 um). Because of such variability, caution should be exercised when
using morphology for identification purposes. H. hepaticus has many identifying biochemical
characteristics. It is urease, oxidase, and catalase positive, produces hydrogen sulfate, reduces
nitrate to nitrite (Rice, 1995), and will only grow at 370C under microaerophilic conditions
containing 90% N2, 5%H2, 5%CO2 (Fox et al., 1994). In culture it typically grows as a spreading
film and is difficult to isolate from clinical specimens. For example, commensal bacteria from a
typical fecal specimen tend to overgrow and impede the identification of H. hepaticus. It is
possible to pass specimens through a 0.45 um filter to select for H. hepaticus, but this adds an
additional processing step for isolation (Weisbroth, 1999). Because of special requirements for
isolation, culture is not a viable means of diagnosis. Polymerase chain reaction (PCR) analysis is
considered the Gold Standard for detection of H. hepaticus because of its increased sensitivity
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and specificity over other methods (Battles et al., 1995; Beckwith et al., 1997; Riley et al., 1996;
Shames et al., 1995).
The incidence of H. hepaticus infection in mice is unknown, but is thought to be quite
high (Baker, 1998; Riley et al., 1996; Zenner, 1999). Evaluation of 28 strains of mice from four
commercial venders in 1995 revealed a 34% overall incidence of H. hepaticus (Shames et al.,
1995). Transmission occurs through the fecal-oral route, and may also potentially be transmitted
through contaminated fomites (Beckwith et al., 1997; Livingston et al., 1998; Whary et al.,
2000). Other potential routes of transmission reported include transplacental infection in
immunodeficient mice (Li et al., 1998) and through the use of contaminated human tumor
xenografts in SCID mice (Goto et al., 2001).
Helicobacters can be divided into two major groups: gastric and enteric forms. Enteric
helicobacters have the ability to colonize the lower intestinal tract and may or may not colonize
the hepatic system as well. H. hepaticus is an enteric helicobacter that can be found in biliary
canaliculi, liver parenchyma, gut lumen, cecal mucosa, and colonic mucosa (Dubois, 1998).
Since its initial discovery, there have been numerous reports of adverse health conditions
associated with H. hepaticus infections in mice. H. hepaticus is responsible for the development
of hepatitis (Fox et al., 1996a, 1996b; Li et al., 1998; Ward et al., 1994) and associated liver
tumors (Diwan et al., 1997; Ihrig et al., 1999; Rice, 1995; Ward et al., 1994), proliferative
typhlitis and colitis (Erdman et al., 2001; Fox et al., Li et al., 1998), as well as inflammatory
bowel disease (Cahill et al., 1997; Foltz et al., 1998; Ward et al., 1996).
Not all strains of mice are equally susceptible to H. hepaticus infection. Host strains that
are considered susceptible to developing disease and lesions associated with infection are SCID,
A/J, C3H/HeN, BALB/cAN, DBA/2 N, CBA/J, and all other immunodeficient mice (Weisbroth,
2

1999). Mouse strains considered resistant to developing lesions associated with infection but are
enteric carriers of the bacteria are C57BL/6N, B6C3F1, B6D2F, and CD2F1 (Weisbroth, 1999).
Although both sexes are susceptible, infections in males are more severe and have a higher
incidence of lesions. These become progressively more severe over time (Fox et al., 1996a;
Ward et al., 1994).
Currently, there are three known virulence factors for H. hepaticus. First, H. hepaticus
produces urease which is characteristic of gastric helicobacters (Beckwith et al., 2001). A byproduct of urea metabolism, ammonia, serves as a direct tissue irritant (Smoot et al., 1990) and is
thought to increase the local gastric pH to ensure survivability during passage through the highly
acidic environment of the stomach (Beckwith et al., 2001). Urease also has the ability to
independently activate neutrophils and inflammatory cytokines responsible for liver lesions
(Dubois and Phadnis, 1998). Second, a soluble protein granulating cytotoxin was discovered
after several unsuccessful attempts to isolate H. hepaticus from severe liver lesions in certain
strains of mice, particularly A/JCr mice. When in contact with hepatocytes, the cytotoxin causes
cells to become dense and granular in appearance (Taylor et al., 1995). Third, a cytolethal
distending toxin causes progressive cell enlargement and eventual death (Chien et al., 2000).
This toxin also plays a role in the pathogenesis of several other bacterial species, such as
Campylobacter spp., Escherichia coli, Shigella dysenteriae, Haemophilus ducreyi, and
Actinobacillus actinomycetemcomitans (Young et al., 2000). The granulating cytotoxin and
cytolethal distending toxin can act synergistically to cause liver damage, but their exact role in
the pathogenesis of H. hepaticus infections has yet to be determined.
Most normal immune competent mice show no clinical signs of illness associated with H.
hepaticus infection. Mice that are immune compromised frequently develop tenesmus and
3

subsequent rectal prolapse (Baker, 1998; Ward et al., 1996). With high prevalence of infection
and rare clinical signs to indicate illness, there is concern over H. hepaticus’ impact on research.
One of the most well documented incidences of H. hepaticus infection adversely affecting
research involved the National Cancer Institute – Frederick Cancer Research and Development
Center. Retrospectively, H. hepaticus was found infecting mice in nine of 12 carcinogenesis
studies. Infected mice had an increased incidence of hepatic neoplasms when compared to
negative control mice and thus results from these studies were confounded (Hailey et al., 1998).
This particular event began a movement to eradicate Helicobacter spp. infections in all
laboratory research animals.
Historically, methods to eradicate Helicobacter species from rodent colonies involved the
use of antibiotics, cesarean rederivation, or embryo transfer. Although antibiotic therapy is
beneficial in eradication, it is not practical if the goal is to rederive large numbers of animals.
Also, literature reports are conflicting as to the effectiveness of antibiotics for eradication. One
study indicated success using amoxicillin monotherapy (Russell et al., 1995), whereas others
indicated success using only amoxicillin or tetracycline-based therapy in conjunction with
bismuth and metronidazole (Foltz et al., 1995, 1996). Cesarean section and embryo transfer are
proven methods of rederivation, but are labor intensive, expensive, and time consuming,
generally requiring sacrifice of valuable breeders.
An alternative method for producing Helicobacter-free animal colonies through fostering
of newborns was used to develop H. pylori-free rhesus monkeys (Solnick et al., 1999). Results of
one study (Lipman et al., 1987) indicated eradication of mouse hepatitis virus and mouse
encephalomyelitis virus from mouse colonies through similar fostering systems. From the results
of those studies, it seemed reasonable to use this strategy to generate Helicobacter-free mice.
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This method would clearly have advantages over other rederivation methods. It is technically
simple and cost effective, does not require surgical expertise, and does not sacrifice valuable
breeders. Truett and coworkers (2000b) first used neonatal fostering to derive Helicobacter-free
mice. On the first day of life, litters were transferred from Helicobacter-positive to Helicobacterfree dams. Fostered pups remained free of Helicobacter spp. for the duration of the project.
However, the maximal age at which mouse pups can be fostered and remain uninfected is
unknown. This information is necessary to establish guidelines for neonatal fostering. Thus, the
purpose of this study was to determine the optimal age at fostering for the derivation of H.
hepaticus-free mice. The hypothesis tested was that C57BL/6 mouse pups must be fostered
within 24 hours of parturition to remain H. hepaticus-free.
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MATERIALS AND METHODS
Animals. Mice were maintained in the vivarium of the School of Veterinary Medicine at
Louisiana State University. All facilities are accredited by the Association for the Assessment
and Accreditation of Laboratory Animal Care, International. The study was approved by the
Louisiana State University Institutional Animal Care and Use Committee.
The C57BL/6 mice, two to six months old, were purchased from a commercial
Helicobacter-free colony (Harlan, Indianapolis, Ind.) and were used as donors. Helicobacter-free
BALB/c mice of similar age were also purchased and used as foster dams for the C57BL/6
mouse pups. Mice were quarantined for three weeks after arrival, and their Helicobacter-free
status was confirmed in our laboratory, using polymerase chain reaction (PCR) testing of fecal
pellets from each mouse (Truett et al., 2000b). All mice were housed in static polycarbonate
Micro-Isolator™ cages (Lab Products, Inc., Seaford, Del.) on corn cob bedding (Bed-O’ Cob,
Anderson’s Inc., Maumee, Ohio). Room conditions were maintained by use of a 12/12h
light/dark cycle at 22 to 240C and 40 to 60% humidity. The C57BL/6 and BALB/c colonies were
kept in separate rooms under negative-pressure ventilation. Access to these rooms was restricted
to prevent cross contamination once the C57BL/6 mice were experimentally inoculated. The
BALB/c mice were kept under a positive-pressure HEPA-filtered ventilation unit constructed in
house (Figure 1). The C57BL/6 mice were housed as breeding pairs, and BALB/c mice were
housed two to three females per male initially, with females individually housed after visual
confirmation of pregnancy. The C57BL/6 mice were given ad libitum access to tap water and
feed (Purina Lab Diet 5001, PMI Nutrition International, Inc., Brentwood, Mo.). The BALB/c
mice were given ad libitum access to autoclaved tap water and feed (Purina Lab Diet 5010, PMI
Nutrition International, Inc., Brentwood, Mo.). Caging and bedding for BALB/c mice were also
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autoclaved before use. All cage bedding was changed twice weekly. Bedding of all BALB/c
cages as well as foster dams with C57BL/6 pups were changed in front of a positive-pressure
laminar flow unit (NUAIRE, Plymouth, Minn.). All surfaces of the changing table were wiped
with dilute Nolvasan® (Chlorhexidine diacetate) solution between cages. Gloves were either
changed or dipped in dilute Nolvasan® solution between each cage.

Figure 1. The HEPA-filtered ventilation unit for the BALB/c mice. Note that mice are housed in
static polycarbonate Micro-Isolator™ cages under positive-pressure airflow.

Preparation of Inoculum. Helicobacter hepaticus was purchased from the American
Type Culture Collection (ATCC No. 51449; 16S rRNA GenBank accession No. U07573). Our
sample was revived according to manufacturer’s directions with one modification. Dried
material was transferred to one milliliter of liquid medium, blood agar plates were inoculated
with 110 ul each of rehydrate, and plates were placed in gas canisters (BBL GasPak System,
Cockeysville, Md.). Oxygen was vacuumed out of GasPak Systems, using 760 mmHg (30 inches
of Hg) pressure and was replaced with an anaerobic gas mixture of 80%N2, 10%CO2, 10%H2.
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Plates were incubated at 370C for two to three days. Growth of H. hepaticus on the blood agar
plates was verified via preparation of wet mounts and observation using phase contrast
microscopy. Helicobacter hepaticus (ATCC No. 51449) was used as a positive control to
validate the PCR assays in this experiment (Figure 2).

1 2 3 4 5 6 7 8 9

Figure 2. Fecal polymerase chain reaction (PCR) assay results from day 2 C57BL/6 foster pups
(lanes 3-9) that were positive for Helicobacter hepaticus. H. hepaticus (375-bp fragment) in
lane 2 was used as a positive control to validate the assay.

Experimental Induction of Infection. The C57BL/6 mice were inoculated with H.
hepaticus, paired, and allowed to breed. Simultaneously, Helicobacter-free BALB/c mice were
paired for breeding so foster dams would be available when C57BL/6 mouse pups were born.
Mice were gavaged with 0.2 ml of bacterial suspension having spectrophotometric optical
density readings between 0.575 A and 1.172 A at 660.0 nm. Gavage was performed, using a
22-gauge 11/2-inch, straight gavage needle every other day, for a total of three doses (Cahill et
8

al., 1997). A suspension was prepared fresh daily by transferring growth of H. hepaticus from
blood agar plates with sterile cotton tipped applicators to Brucella broth containing 5% fetal
bovine serum.
Fostering. Beginning on the day of birth (day 1), 20 C57BL/6 mice were fostered onto
Helicobacter-free BALB/c dams each day for 14 days. A total of 280 C57BL/6 mouse pups from
50 litters were fostered. Each morning before 10:30 AM, one individual observed the C57BL/6
mice and recorded the birth of any new litters. At the same time, a different individual recorded
new BALB/c births and selected dams with litters of approximately similar age to serve as foster
mothers. The foster dam’s natural litter was then removed and gently covered with lightly
scented talc powder (Kuddles, Winn Dixie Stores, Inc., Jacksonville, Fla.) using gloved hands. A
person observing the C57BL/6 mice hand-carried the selected foster pups to the BALB/c colony
room and waited for them to be received. The C57BL/6 foster pups were passed to the powdered
and gloved hands of an individual holding the BALB/c foster dam’s natural litter. The two litters
were briefly mixed together, and the foster pups were placed in the BALB/c foster dam’s cage
(Figure 3). Thereafter, the foster dam’s Micro-Isolator™ box was moved from the HEPA-filtered
ventilation unit to a separate nonventilated rack across the room. This precluded pathogen
transmission from foster pups to uninfected BALB/c dams. Dams successfully accepted from
one to 12 (mean, 5.6) foster pups. In instances where the foster dam showed aggression toward
the fostered pups, one or two natural pups were returned to the dam. Foster pups from individual
fostered litters were weaned at 21 days of age and group housed by sex. After foster pups were
weaned, their BALB/c foster dams were euthanized by CO2 asphyxiation.
In an effort to verify shedding of H. hepaticus and, therefore, ensure exposure of the
mouse pups, fecal PCR assays were performed every two weeks on the adult C57BL/6 mice for
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the duration of the study. Litters were chosen for fostering if one or both parents were shedding
bacteria within seven days before or after parturition. Also, random, routine screening of
BALB/c foster mice via fecal PCR analysis was performed to verify continual H. hepaticus-free
status. At times a BALB/c dam could not be used before it was time to wean her natural litter. In
these instances, the natural litter was weaned and used to replenish foster breeders. As with other
BALB/c mice, they were routinely evaluated by use of fecal PCR analysis to verify their
continual Helicobacter-free status.

Figure 3. A BALB/c dam with newborn C57BL/6 foster pups. Note that the C57BL/6 pups are
pink at birth. Coat color does not fully develop until a few weeks after birth.

Specimen Collection. At weaning (21 days of age) a fecal specimen was collected from
each pup for PCR determination of Helicobacter status. Pups were restrained by scruffing the
skin on the dorsal aspect of the neck, held over a collection tube, and allowed to defecate directly
into the collection tube. Right lateral and caudate liver lobes, a longitudinal half section of
cecum, and a fecal pellet were collected in that order from mice euthanized via CO2 asphyxiation
at 42 days of age. Instruments were sterilized between mice for approximately 30 seconds using
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a bead sterilizer (Germinator 500, CellPoint Scientific, Inc., Rockville, Md.). Liver and cecal
tissues were immediately frozen in liquid nitrogen and stored at -700C for future PCR assays.
Cecal contents were gently removed before freezing.
Extraction of DNA and PCR Analysis. Polymerase chain reaction analysis was chosen
for detecting infections since it is considered the Gold Standard for identification of
Helicobacter species. On the day of collection, DNA was extracted from feces, using the hot
sodium hydroxide and tris (HotSHOT) method (Truett et al., 2000a). Briefly, a fecal pellet was
mixed in an alkaline lysis solution (3 ml 25 mM NaOH/0.2 mM EDTA), placed in a 950C water
bath for 10 minutes, then centrifuged for one minute at 1000 xg to pellet debris. Equal parts of
supernatant and buffer solution (40 mM Tris HCl) were combined and stored at -200C until used
for PCR analysis. The PCR assay conditions were as described (Truett et al., 2000b) using
Helicobacter genus-specific primers, 5'-TATGACGGGTATCCGGC-3' and 5'ATTCCACCTACCTCTCCCA-3', designed from the conserved region of the 16S rRNA gene of
the Helicobacter genus (Beckwith et al., 1997). Assays were amplified in a Robocycler
(Stratagene, La Jolla, Calif.) for 50 cycles. Following amplification, 20 ul of PCR product were
electrophoresed in a 1% agarose gel. Results were documented by photography after ethidium
bromide staining and ultra violet illumination.
Liver and cecal DNA were extracted using a commercially available kit (Qiagen Inc.,
Valencia, CA) according to manufacturer’s instructions. Extracted specimens were stored at
-200C until PCR analysis was done. The tissue PCR assays were performed as described for fecal
samples.
Field Trial. A field trial was conducted at the Pennington Biomedical Research Center,
Baton Rouge, La. The goal of this trial was to clear all mouse strains within the facility of
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Helicobacter spp. by using neonatal transfer prior to housing them in the barrier portion of the
facility. Mice fostered included 22 inbred, 20 transgenic, 23 knockout, and six congenic strains
(See Appendix A). On the basis of health surveillance of C3H/HeJ and BALB/c sentinel animals,
all animals in the barrier facility are verified free of Helicobacter spp., as well as Sendai virus,
pneumonia virus of mice, mouse hepatitis virus, Mycoplasma pulmonis, minute virus of mice,
reovirus type 3, Theiler’s mouse encephalomyelitis virus, lymphocytic choriomeningitis virus,
ectromelia virus, and polyoma virus. Helicobacter-free BALB/c and C57BL/6J mice were used
as foster dams for mouse pups. Mouse pups were fostered within 24 hours of birth using the
same technique as previously described for the experimental study. Pups verified negative by
fecal PCR analysis at 21 and again at 42 days of age were transferred to the Helicobacter-free
barrier. Helicobacter status was monitored in the barrier through the use of dirty bedding transfer
to sentinels (Beckwith et al., 1997; Livingston et al., 1998; Whary et al., 2000). Sentinels were
checked for Helicobacter spp. by use of fecal PCR analysis quarterly as part of their routine
microbiological surveillance program. Approximately 10 months after fostering, follow-up fecal
PCR analysis was randomly performed on 52 litters representing 52 strains. These mice included
15 inbred, 14 transgenic, 19 knockout, and four congenic strains. At that time, many of the
originally fostered mice were no longer in the facility as a result of being sold or termination of a
project. These mice were representative of the total population of 201 litters fostered from 71
strains similarly processed.
Cyclic Shedding Study. Although the fostering protocol only lasted approximately 23
weeks, fecal PCR analysis was continued on the adult C57BL/6 mice. Fecal specimens were
collected every two weeks, as previously described, for an additional 16 weeks to determine their
shedding status (39 weeks total).
12

Statistics. Fecal, liver, and cecal PCR results were analyzed, using one-way analysis of
variance (ANOVA) to detect differences in percentage of positive tests between assay methods.
Any mouse determined positive by at least one PCR assay at the time the gel was interpreted,
was considered to be infected with H. hepaticus. The PCR results were also analyzed by use of
one-way ANOVA to detect differences in the percentage positive pups between weaning (day
21) and euthanasia (day 42) fecal specimens. Results were considered significant at P < 0.05.

13

RESULTS
Fostering. The method of fostering with talc powdered gloves proved successful, since at
times, 14-day-old C57BL/6 mouse pups were transferred onto BALB/c foster dams with
newborn litters. The BALB/c dams demonstrated good maternal behavior, as most of them
accepted foster litters of various ages and phenotype different from their own (Figure 4). Only
two of 54 BALB/c foster dams actually harmed pups in their foster litter. The dams that showed
initial aggression toward their foster litter calmed considerably if one or more of their natural
pups were returned to the cage. To use as many pups as possible, litters were sometimes split or
combined at the time of fostering. Only litters of the same postnatal age were combined, and
they remained together until weaning at which time they were housed by sex. With one
exception, all fostered pups were weaned at 21 days of age and were euthanized at 42 days of
age. One litter’s wean date was miscalculated to be 10 days late, but members were euthanized at
the appropriate time.

Figure 4. A BALB/c dam with C57BL/6 foster pups before weaning.
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Fecal PCR Assay for Adult C57BL/6 Mice. After inoculation, the C57BL/6 adults were
screened by use of fecal PCR analysis every two weeks to confirm shedding status before
fostering. In 20 of 168 cases (12%), both parents failed to shed H. hepaticus. In no instance was
a litter fostered at those times; therefore, lack of Helicobacter shedding in the adult C57BL/6
mice did not reduce opportunities to foster pups. One litter (day 5) had parents shedding bacteria
within 10 days of fostering rather than within seven days of parturition. These fostered pups
apparently received adequate exposure to the bacteria since two of four (50%) pups were
positive at weaning and three of four (75%) pups were positive at euthanasia.
Fecal PCR Assay for BALB/c Mice. During routine fecal PCR assay to confirm
negative status of the BALB/c colony, one of the juvenile pups that was to be used as a future
foster mouse was determined positive for Helicobacter sp. All mice that had direct or indirect
contact with the suspect mouse, including the dam, sire, siblings, and all females that were mated
to the sire, were euthanized. The dam of this suspect mouse was never used as a foster dam, and
no other positives were found in the BALB/c colony.
Polymerase Chain Reaction Assay for Fostered C57BL/6 Mice. To determine the
percentage of positive pups by use of PCR assay, fecal specimens were obtained from each
fostered mouse at weaning and at euthanasia (Figure 5). None of the mice fostered within 24
hours of parturition (day 1) were positive for H. hepaticus at weaning or euthanasia, but
exposure to shedding parents from 24 to 48 hours post-parturition (day 2) resulted in eight (40%)
of the fostered pups becoming positive for H. hepaticus at weaning and euthanasia. With the
exception of day 2, the percentage of positive pups was always higher at euthanasia than at
weaning. In fact, most pups became infected when allowed more than two days of exposure to
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shedding parents. At euthanasia, 76% of the fostered pups were determined positive by use of
fecal PCR analysis. Only 52% of the fostered pups were determined positive by use of fecal PCR
analysis at weaning. This difference in infection rate was statistically significant (P = 0.02).
Liver and cecal tissues were collected following euthanasia to verify fecal results. The
PCR analysis of liver specimens from mice from separate litters fostered on day 1 revealed two
questionably positive specimens. Likewise, there were six questionable cecal specimens. None
of these suspect-positive samples had corresponding positive results in the other two assays. For
example, the suspect-positive liver specimens had negative fecal and cecal PCR results. These
samples were reprocessed. After reprocessing, only two cecal tissues, each from separate litters,
remained questionable. The DNA sequencing on PCR products from these specimens (Figure 6A
and 7A) was performed by GeneLab (Louisiana State University, Baton Rouge, La). Relevant
alignments matched with the Helicobacter genus, using Basic Local Alignment Search Tool
(National Center for Biotechnology Information homepage [<(www.ncbi.nlm.nih.gov/ )>]). One
alignment match had 91% homology (Figure 6B) whereas the other alignment match had 98%
homology to H. hepaticus (Figure 7B).
Results of tissue PCR analysis for days 1-14 are presented in Figure 5. The percentage of
positive livers found remained consistently low and fluctuated greatly. Liver PCR analysis only
detected a mean 7.5% of infections, indicating that H. hepaticus seldom colonizes the liver of
C57BL/6 mice. Liver PCR results were significantly different from both fecal and cecal PCR
results (P < 0.01). In contrast, PCR assay, utilizing fecal versus cecal specimens revealed
equivalent numbers of positive specimens. Polymerase chain reaction analysis, using cecal and
fecal specimens, revealed 85% and 76% positive specimens, respectively.
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Figure 5. Comparison of results of fecal, liver, and cecal polymerase chain reaction (PCR)
assays for detecting Helicobacter hepaticus infections in C57BL/6 mice fostered on the indicated
days after birth. Fecal-D21 are fecal specimens collected at weaning (21 days of age). Fecal-D42
are fecal specimens collected at euthanasia (42 days of age). Liver and cecal tissues were
collected at euthanasia.
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A

B

Figure 6. A) DNA sequencing of suspect positive (day 1) cecal specimen number 1 that
remained positive after reprocessing. B) Corresponding base pair alignment having 91%
homology to Helicobacter hepaticus.
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A

B

Figure 7. A) DNA sequencing of suspect positive (day 1) cecal specimen number 2 that
remained positive after reprocessing. B) Corresponding base pair alignment having 98%
homology to Helicobacter hepaticus
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Field Trial. A large field trial, using neonatal fostering on the day of birth to rederive
several strains of mice, began in June of 2000 at the Pennington Center. The trial produced 201
litters representing 71 strains of Helicobacter-free mice. Mice were transferred to the barrier
portion of the facility only after they tested negative for Helicobacter spp. by use of fecal PCR
analysis at 21 and 42 days of age. Fecal specimens were again collected for PCR analysis
approximately 100 days after fostering from mice representing 43 litters as well as from nine
offspring to determine whether the animals remained Helicobacter-free. H. hepaticus infections
were not found in any of the fostered animals or their progeny. Also, all fecal specimens from
the sentinel program for quality assurance have been tested PCR negative for the past two years.
Cyclic Shedding Study. Fecal PCR analysis was performed on the adult C57BL/6 mice
every two weeks for 39 weeks to determine their shedding status. A cyclic fecal shedding pattern
of H. hepaticus was found (Figure 8). Overall, the male C57BL/6 mice had a higher rate of
shedding than the females. The highest percentage of shedding detected in the females was only
81.25% at 13 weeks whereas 100% of the male mice were found shedding at one point after
experimental inoculation. Also, the percentage of positive males consistently peaked prior to that
of the females. For example, at one point the males had a peak shedding percentage of 100% at
19 weeks and a low shedding percentage of 54.55% at 23 weeks. Two weeks later the females
had a corresponding peak shedding percentage of 54.55% at 21 weeks and a low of 0% shedding
at 25 weeks.
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Figure 8. Fecal shedding of Helicobacter hepaticus in adult C57BL/6 mice after experimental
inoculation. The blue line (diamonds) represents the percentage of males shedding the bacteria.
The pink line (squares) represents the percentage of females shedding the bacteria.
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DISCUSSION
Experimentally, neonatal fostering proved to be an effective means of deriving
Helicobacter-free mice. The fostering process was technically simple, and should be easily
adapted to any rodent facility. The BALB/c and C57BL/6 mice were selected for use in this
project for a number of reasons. The differences in coat color allowed foster pups to be
distinguished from natural pups. Since the coat is not fully developed until the second week of
life, this technique is useful if the mixed litter is to be maintained through weaning. The BALB/c
mice are proficient breeders, and therefore, consistently provided lactating foster mothers at all
times during the experiment. Also, BALB/c mice reportedly accept fostering more readily than
do some other mouse strains (Brey, 2000). The C57BL/6 mice were chosen as donors because
they also exhibit good maternal behavior. Additionally, many transgenic strains of mice are on a
C57BL/6 background. This allows us to relate our findings to many of the research colonies in
common use. Also, in a recent report (Whary et al., 2001), long-term cecal colonization of
Helicobacter hepaticus was compared in AJC/r and C57BL/6 mice. Although the C57BL/6 mice
did not develop severe hepatitis, they had significantly higher Helicobacter bacterial counts in
the cecum than did the A/JCr mice. In the study reported here, higher bacterial counts may have
worked to our advantage in detecting infected animals.
To determine percentages of foster pups that became positive for H. hepaticus following
exposure to shedding parents, fecal specimens were collected at weaning (21 days of age) and
again at euthanasia (42 days of age). We chose to euthanize the mice at 42 days of age assuming
that bacterial shedding would occur by that time if they were infected. In our study, a high
percentage of fostered pups was infected with H. hepaticus after only 24 hours of exposure.
Overall, a larger percentage of pups were found to be positive at euthanasia than at weaning.
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Mice that were not infected from their shedding parents were likely exposed to the bacteria by
their positive litter mates and subsequently became infected. Although single housing of weaned
pups would have prevented this, we chose to group house weanlings because most facilities
routinely group house mice.
Tissue PCR analysis revealed some unexpected results. Two of the day 1 cecal specimens
appeared weakly positive for Helicobacter spp. Subsequent DNA sequencing revealed a match
with the Helicobacter genus. However, it was concluded that these samples represented falsepositive results, and were likely contaminated with amplification product from previous assays,
or less likely, were contaminated during necropsy. This conclusion is supported by the results of
our field trial in which 52 fostered litters and/or their progeny remained Helicobacter free for an
average of 100 days after fostering. Therefore, although it is possible that a few mice became
infected within 24 hours of birth, the preponderance of data supports the conclusion that none of
the mice fostered before 24 hours of age were fecal PCR positive at weaning or at euthanasia.
This conclusion is also consistent with the report by Truett and coworkers (2000b), who fostered
84 mice within 24 hours of birth. In that study, all mice remained Helicobacter free.
Liver PCR analysis was least reliable for detecting mice infected with H. hepaticus.
Similar results were described in a report by Whary and coworkers (2001), in which none of
their experimentally infected C57BL/6 mice were found to have liver infection on the basis of
results of PCR analysis. It has been reported that liver colonization may not be detectable until
mice are at least three months of age (Riley et al., 1996). This may be a possible explanation for
the poor detection of infection, on the basis of liver PCR analysis, especially since our mice were
only 42 days old when they were euthanized. Cecal and fecal PCR analysis detected more
infections than did liver PCR analysis, thus indicating that the former are preferred for detection
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of H. hepaticus infection. These observations agree with those of Riley and coworkers (Riley et
al., 1996), who suggested that intestinal, over other target, tissues yield better results. Also, in a
study comparing diagnostic methods of detecting Helicobacter spp., high correlation between
fecal and cecal PCR analysis were reported (Mähler et al., 1998). These findings agree with the
results of our study. Others reported perfect correlation between fecal and cecal PCR analysis for
the detection of H. hepaticus in A/JNCr mice; however, they used a mouse strain known to be
more prone to developing lesions and clinical disease due to Helicobacter infection (Beckwith et
al., 1997; Fox et al., 1996a; Ward et al., 1994; Weisbroth, 1999). Taken together, these results
suggest that both cecal and fecal PCR assays are reliable methods for evaluating mouse
populations.
Results of the Pennington Center field trial confirmed that neonatal fostering is a reliable,
simple, and cost effective method to rederive Helicobacter-free mice. Unlike traditional methods
of rederivation, neonatal fostering did not require surgical expertise, and allowed reuse of
valuable breeders. Mouse strains known to be susceptible to Helicobacter infection were used
for sentinel monitoring in the barrier. This likely increased the chances of detecting infections
(Beckwith et al., 1997; Fox et al., 1996a; Ward et al., 1994; Weisbroth, 1999). To date,
infections have not been detected in sentinels, or by follow-up fecal PCR analysis performed on
several mice approximately 100 days after fostering. Neonatal fostering was also used
successfully to derive 13 litters representing three strains of Helicobacter-free rats (unpublished
data).
On the basis of our results, mice must be fostered within 24 hours of birth to prevent
transmission of H. hepaticus from infected parents to susceptible offspring. Several important
factors should be considered if neonatal fostering is to be used successfully as a method of
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rederivation for H. hepaticus. Mice must be consistently examined for newborn litters at
approximately the same time each day to ensure that a 24-hour postparturition period has not
been exceeded. In our study, pups were hand carried from the contaminated to the clean room. In
larger facilities, where rooms are separated by greater distances, pups should be transported in a
clean and covered mouse box. Cage containment is important and should include use of cage-top
filters, especially if infected mice are also present within the animal room. Personnel should
never enter clean rooms after infected rooms have been entered, and traffic in clean rooms
should be kept to a minimum. Lastly, it is unknown whether donor or foster mouse strain may
affect the success of rederivation efforts. However, it should be noted that, in the field trial, a
large number of donor mouse strains were used with equal success.
Through the use of fecal PCR analysis, we demonstrated a cyclic shedding pattern of H.
hepaticus in adult C57BL/6 mice. Unlike previous reports, at no one time were 100% of the mice
shedding the bacteria. Truett and coworkers (2000b) reported that mouse pups raised by
Helicobacter-positive dams were all fecal PCR assay positive after 19 days of exposure. Also, a
separate study demonstrated that all mice became positive based on fecal PCR analysis after four
weeks of exposure through dirty bedding transfer (Livingston et al., 1998). Neither of these
studies followed the infections long term to verify if the shedding status would consistently
remain. The male C57BL/6 mice consistently had a higher percentage of shedding than the
females and may be considered a constant source of contamination for the females. This may be
in part due to the investigative and coprophagic nature of the male mice and the fact that C7BL/6
mice carry high H. hepaticus loads in the lower bowel (Whary et al., 2001). From these
observations, it seems that the male mice may expose the newborn pups to greater bacterial loads
than might be expected if the female was housed alone.
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There is still much to be learned by studying Helicobacter hepaticus. Further studies
must be performed to determine if this fostering technique will be successful in mouse strains
that are of a known immune compromised state. Since the male C57BL/6 mice seem to shed
most of the bacterial load and are thus responsible for more of the mouse pup exposure, further
studies are underway to determine if fostering can be performed successfully after 24 hours of
birth if the sires are removed from the dam’s cage before parturition. Also, studies are currently
underway to further evaluate whether there is a positive correlation between bacterial load of H.
hepaticus and different gender based housing schemes. Results of this study should offer
valuable information about the transmission of H. hepaticus and lead to the development of
further recommendations for eradication in animal research facilities.
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APPENDIX A: MOUSE STRAINS USED IN THE FIELD TRIAL
Mouse Identification
129/AKRJ bs/+
129p3J
129S3/sv imj
129UCP1TM1
A/J
A4/SWRJ
A9/HOMO
AJ x MC4 (-/-)
AKR GDC-1
AKR/J
AXB10
AXB8
AXB1
AXB8 UCP1TM1
B10.LP 35 NS/SN
B10.LP (JR 412)
B1126 x MCJR (+/-) 65441
B6 CRE #14
B6 GDC-1
B6 Lep (OB) UCP1
B6 UCP CRE #13
B6 129-ins/+
B6 129S-Vamp 8 TM/LEX
B6 903 F1
B6C3FE ANX A/+a/het
B6IBA
B6LEP OB Jax
B6-Lpa1
BALB GP JUNCA
BALB/CBY ACADS +/+ UCP1 TM3
BALB/CHEA
BALB/CHEA GDM KO29
BALB/CHEA GDM KO15
BALB/CHEA-GDC 1 NULL
BALBCBY
BALBCBY UCP 1TM2
BALBCBYJ 5461
BALBCBYJ ACADS (-/-)
Beta 3 KO
B10.LP 420
B10.LP H13/SN
B6xB10UWCast
BXA12
C57BL (Jax)
C57BL 10SNJ
C57BLxMC3A (+/-)
C57BLxMC4 (-/-)
C57xMCJR (+/-)
C57BL/6J GDM KO16

Strain Type
I
I
I
K
I
C
C
T
T
I
I
I
I
K
C
C
T
T
T
K
T
I
T
I
K
C
K
C
K
K
I
K
K
K
I
K
I
K
K
I
I
I
I
I
I
T
T
T
K
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Follow-Up PCR*
No
Yes
Yes – progeny
Yes
Yes
No
No
No
Yes
No
Yes – progeny
Yes – progeny
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes – progeny
No
Yes
Yes
Yes
Yes – progeny
Yes
No
Yes
Yes – progeny
No
Yes
Yes
No
No
No
No

(Table 1 continued)

(Table 1 continued)
C57BL/6J UCP 1TM1
C57BL/6 NRF 2
C57BL/6J ap2
C57BL/6J GDM KO15
C57BL/6J GDM KO29
C57BL/6J x CRE-LAC
C57BL/6J x CRE-LACZ
C57BLHTR2C 2661
Cast EI 6283
DBH
FVB Beta3KO
GLP1R 5225
HTR2C
LCAD (-/-) 4965
LCAD
LDOPS
LP/J
LPL
MC3R (+/-) x C57BL
MC3R (+/-)
P613/CREA Pro 220
SWR-GDC-1

K
K
T
K
T
T
T
T
I
I
K
K
T
K
K
K
I
T
T
T
T
K

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes – progeny
Yes – progeny
No
Yes
Yes
Yes – progeny
Yes
Yes
Yes
Yes
Yes
No
Yes
No
Yes

Table 1. Strains of mice fostered in the Pennington Biomedical Research Center field trial.
*Follow-up fecal polymerase chain reaction (PCR) analysis was performed on those strains
indicated by ‘yes’ approximately 100 days after fostering. Follow-up fecal PCR assay was
occasionally performed on the offspring of originally fostered mice which are indicated by the
word ‘progeny’.
I = inbred; K = knock out; C = congenic; T = transgenic
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APPENDIX B: FECAL POLYMERASE CHAIN REACTION (PCR) ANALYSIS
DATA FOR ADULT C57BL/6 MICE
DATE

WEEK

MALE

FEMALE

TOTAL

11/26/00

4

15/16 (93.75)

9/20 (45)

24/36 (66.67)

12/20/00

7

11/16 (68.75)

9/17 (52.94)

20/33 (60.61)

1/1/01

9

14/15 (93.33)

8/16 (50)

22/31 (70.97)

1/15/01

11

14/15 (93.33)

7/16 (43.75)

21/31 (67.74)

1/29/01

13

14/15 (93.33)

13/16 (81.25)

27/31 (87.10)

2/12/01

15

13/15 (86.67)

12/15 (80)

25/30 (83.33)

2/26/01

17

10/15 (66.67)

7/15 (46.67)

17/30 (56.67)

3/12/01

19

12/12 (100)

6/12 (50)

18/24 (75)

3/26/01

21

9/11 (81.82)

6/11 (54.55)

15/22 (68.18)

4/9/01

23

6/11 (54.55)

2/11 (18.18)

8/22 (36.36)

4/23/01

25

7/11 (63.64)

0/11 (0)

7/22 (31.82)

5/7/01

27

7/11 (63.64)

2/11 (18.18)

9/22 (40.91)

5/21/01

29

7/11 (63.64)

4/11 (36.36)

11/22 (50)

6/4/01

31

10/11 (90.91)

6/10 (60)

16/21 (76.19)

6/18/01

33

8/11 (72.73)

8/10 (80)

16/21 (76.19)

7/2/01

35

6/11 (54.55)

6/10 (60)

12/21 (57.14)

7/16/01

37

5/11 (45.45)

6/10 (60)

11/21 (52.38)

7/30/01

39

10/11 (90.91

4/10 (40)

14/21 (66.67)

Table 2. Percentage of adult C57BL/6 mice shedding Helicobacter hepaticus, based on fecal
PCR analysis, at the indicated week after experimental inoculation. Numbers in parentheses
indicate the percentage of mice shedding the bacteria for that given week.
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APPENDIX C: FECAL, LIVER, AND CECAL POLYMERASE CHAIN REACTION
(PCR) ANALYSIS DATA FOR FOSTERED C57BL/6 MICE
Foster Day

Day 21 – Fecal

Day 42 – Fecal

Day 42 – Liver

Day 42 – Cecum

1

0/20 (0)

0/20 (0)

0/20 (0)

0/20 (0)

2

8/20 (40)

8/20 (40)

0/20 (0)

12/20 (60)

3

10/20 (50)

13/20 (65)

2/20 (10)

18/20 (90)

4

9/20 (45)

19/20 (95)

3/20 (15)

18/20 (90)

5

9/20 (45)

15/20 (75)

5/20 (25)

16/20 (80)

6

11/20 (55)

18/20 (90)

1/20 (5)

20/20 (100)

7

7/20 (35)

10/20 (50)

4/20 (20)

15/20 (75)

8

5/20 (25)

16/20 (80)

3/20 (15)

19/20 (95)

9

12/20 (60)

18/20 (90)

0/20 (0)

20/20 (100)

10

12/20 (60)

20/20 (100)

0/20 (0)

20/20 (100)

11

16/20 (80)

19/20 (95)

1/20 (5)

20/20 (100)

12

16/20 (80)

20/20 (100)

2/20 (10)

20/20 (100)

13

15/20 (75)

20/20 (100)

0/20 (0)

20/20 (100)

14

16/20 (80)

18/20 (90)

0/20 (0)

20/20 (100)

Table 3. Infections detected by fecal, liver, and cecal polymerase chain reaction (PCR) assays. A
total of 20 C57BL/6 pups were fostered on each day. The number in parentheses is the
percentage of positive infections detected for that particular foster day. The day 21 fecal
specimen was collected at weaning. The day 42 fecal, liver, and cecal specimens were collected
at euthanasia.
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